BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1937413)

  • 1. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
    Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
    Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions.
    Steinbeck ZR; Heselmeyer KM; Gerlach B; Björnhagen V; Auer GU
    Melanoma Res; 1996 Feb; 6(1):37-43. PubMed ID: 8640068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    Hussein MR
    J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.
    Winokur TS; Palazzo JP; Johnson WC; Duray PH
    J Cutan Pathol; 1990 Dec; 17(6):342-7. PubMed ID: 2074280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nevus and malignant cutaneous melanoma].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
    Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.
    Carr J; Mackie RM
    Br J Dermatol; 1994 Jul; 131(1):72-7. PubMed ID: 8043423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
    Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
    Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K
    Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of naevi-associated BRAF wild-type melanoma and dysplastic naevi under treatment with the class I BRAF inhibitor vemurafenib.
    Göppner D; Müller J; Krüger S; Franke I; Gollnick H; Quist SR
    Acta Derm Venereol; 2014 Sep; 94(5):517-20. PubMed ID: 24531394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric image cytometry of nevi and melanomas.
    Fleming MG; Friedman RJ
    Am J Dermatopathol; 1993 Apr; 15(2):106-13. PubMed ID: 8494109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma--its precursors and its topography of proliferation. DNA-Feulgen-cytophotometry and mitosis index.
    Schmiegelow P; Schroiff R; Breitbart E; Bahnsen J; Lindner J; Jänner M
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):47-59. PubMed ID: 3085340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On naevi and melanomas in dysplastic naevus syndrome patients.
    Crijns MB; Bergman W; Berger MJ; Hermans J; Sober AJ
    Clin Exp Dermatol; 1993 May; 18(3):248-52. PubMed ID: 8348718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma progression.
    Elder DE
    Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy and nuclear morphometry for the classification of dysplastic nevi.
    Williams RA; Baak JP; Meijer GA; Charlton IG
    Anal Quant Cytol Histol; 1999 Oct; 21(5):437-44. PubMed ID: 10560527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid index.
    Berman DM; Wincovitch S; Garfield S; Romeo MJ
    J Clin Pathol; 2005 Nov; 58(11):1206-10. PubMed ID: 16254113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.